文献速递胃肠外科

日本pT1 N+或pT2-3 N0胃癌生存预后因素

Prognostic factors for survival in patients with pT1 N+ or T2-3 N0 gastric cancer in Japan.
PubMed 文献 · Br J Surg · 2017-02-27

结论认为该人群生存良好,年龄65岁及以上、男性和cT2-4与更差总生存相关。

要点

  • 年龄65岁及以上、男性和cT2-4是独立不良预后因素。
  • 该人群总体预后良好,但仍需关注上述高危因素。

核心结论

  • 年龄65岁及以上、男性和cT2-4类别与更差总生存独立相关。

研究设计与样本

  • 多中心回顾性队列研究,纳入日本5个高容量癌症中心2000-2008年间接受治愈性胃切除术的1442例pT1 N+或pT2-3 N0胃癌患者。
  • 收集人口学、临床、手术和病理数据,采用Cox比例风险回归模型识别独立预后因素。

临床怎么用

  • 对于pT1 N+或pT2-3 N0胃癌术后患者,可依据年龄、性别和cT分期识别高危人群并加强随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The outcome for pT1 N+ or pT2-3 N0 gastric cancer is favourable, but some patients suffer from recurrent disease. The aim of this study was to identify prognostic factors in patients with pT1 N+ or pT2-3 N0 gastric cancer. METHODS: This was a multicentre, retrospective cohort study. All patients with pT1 N+ or pT2-3 N0 gastric cancer who underwent curative gastrectomy at five high-volume, specialized cancer centres in Japan between 2000 and 2008 were included. Demographic, clinical, surgical and pathological data were collected. Independent prognostic factors were identified using a Cox proportional hazards regression model. RESULTS: Some 1442 patients were included. The 5-year overall survival rate for patients with pT1 N+ or pT2-3 N0 gastric cancer was 92·0 per cent. Multivariable analysis for overall survival identified age (hazard ratio (HR) 2·67, 95 per cent c.i. 2·09 to 3·43), sex (HR 0·57, 0·39 to 0·83) and clinical tumour depth (cT) (HR 1·45, 1·06 to 1·98) as independent prognostic factors. CONCLUSION: Survival of patients with pT1 N+ or pT2-3 N0 gastric cancer is good. Age 65 years or above, male sex and cT2-4 category are associated with worse overall survival.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Tokunaga M, Ito S, Yoshikawa T, et al. Prognostic factors for survival in patients with pT1 N+ or T2-3 N0 gastric cancer in Japan. Br J Surg. 2017. PMID: 28240355. doi:10.1002/bjs.10509

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。